| Overall Collective | Composite endpoint | No composite endpoint | p composite endpoint vs. no composite endpoint |
---|---|---|---|---|
n | 153 | 26 | 127 | Â |
Age (y) a | 55.6 ± 15.7 | 64.8 ± 14.1 | 53.7 ± 15.4 |  < .001 b |
Sex, % male (n) | 56.2 (86) | 65.4 (17) | 54.3 (69) | .387 c |
Vital signs at admission to ED | ||||
 Heart rate (b.p.m.) a | 87 ± 15.7 | 94 ± 16.7 | 86 ± 15.1 | .010 d |
 Systolic blood pressure (mmHg) a | 130 ± 19.3 | 135 ± 28.0 | 128 ± 16.9 | .096 d |
 Diastolic blood pressure (mmHg) a | 82 ± 15.7 | 84 ± 26.0 | 81 ± 12.8 | .374 d |
 Oxygen demand, % (n) | 45.1 (69) | 76.9 (20) | 38.6 (49) |  < .001 c |
 Respiratory rate (/min) a | 22 ± 6.0 | 26 ± 6.2 | 21 ± 5.6 |  < .001 d |
 NEWS-2 e | 4 (1.5–6) | 7 (5.75–9) | 3 (1–5) |  < .001 b |
Biomarkers | ||||
 bio-ADM (pg/ml) e | 34.5 (22.5–52.5) | 58.8 (40.2–104.1) | 30.4 (21.3–43.6) |  < .001 b |
 IL-6 (pg/ml) e | 32.9 (15.1–69.7) | 107.5 (67.4–241.3) | 26.5 (13.1–50.2) |  < .001 b |
 bio-ADM*IL-6 (pg/ml x pg/ml) e | 1108.3 (432.8–3029.6) | 7243.7 (2443.5–32,699.1) | 853.2 (333.0–2062.6) |  < .001 b |
 Serum creatinine (mg/dl) e | 0.89 (0.75–1.22) | 1.05 (0.85–1.42) | 0.87 (0.72–1.17) | .014 b |
 dpp3 (ng/ml) e | 19.2 (14.5–30.6) | 34.8 (20.8–51.3) | 17.8 (13.2–26.9) |  < .001 b |
 hsTnT (ng/l) e | 8.5 (5.1–14.3) | 16.8 (9.8–54.5) | 6.7 (4.3–12.1) |  < .001 b |
 NT-proBNP (pg/ml) e | 74.4 (50.0–311.0) | 455.5 (86.4–2367.75) | 67.0 (50.0–191.0) |  < .001 b |
 White blood cell count (n/nl) e | 5.53 (4.11–7.49) | 6.98 (4.76–9.78) | 5.12 (3.93–7.22) | .013 b |
 CRP (mg/dl) e | 42.4 (18.6–90.4) | 112.0 (74.0–163.0) | 32.0 (15.5–70.0) |  < .001 b |
 Procalcitonin (ng/ml) e | 0.08 (0.06–0.15) | 0.25 (0.09–0.52) | 0.07 (0.06–0.12) |  < .001 b |